| |
Post-Conference Workshops |
Thursday, June 12th, 2008 |
| |
| |
Workshop A: |
9:00 AM to 12:00 PM |
Designing A Targeted Reimbursement Strategy For Optimal Outcomes In A Niche Disease Market
The health benefits of biologics are becoming more recognized, but each therapy is not a panacea. Targeted therapies for disease subsets require targeted reimbursement strategies to ensure market success and accessibility for patients. Current models of product assessments must be realigned to meet the realities of the market. Come to this workshop for functional and applicable strategies to optimize your reimbursement model. |
- Determine a complete cost-effectiveness analysis to maximize the value proposition
- Establish your disease health states and match your strategy to meet patient needs
- Optimize your use of research, stakeholder consultation, submission, and team training
|
Match the realities of the marketplace with a targeted and integrated reimbursement strategy and ensure positive outcomes in every sense. |
| |
Presented by Calea HealthAccess  |
| |
|
Please note: This is an exclusive workshop for pharmaceutical and biotechnology company representatives only. |
| |
| |
Workshop B: |
1:00 PM to 4:00 PM |
Developing An Integrated Plan To Launch A New Biologic For Research Based Organizations
Many small research based companies have full capabilities for discovering a novel and effective biologic, yet lack the infrastructure and resources to launch successfully the product in Canada. Clinical knowledge and research is just the first step; a strategic integrated plan for manufacturing, distribution and marketing is essential for a successful launch. This practical workshop will help your organization to… |
- Ensure you determine the requisite reimbursement and economic data to obtain coverage
- Take steps to secure licensing, and distribution or agency agreements for logistics
- Overcome a host of post-NOC challenges
- Determine the optimal sales, marketing and distribution strategies for your product
|
Get all the tools you need to ensure the successful commercialization of your new biologic. |
Rod Wilson, Senior Partner, Cameron Stewart LifeScience Inc. |
| |
| |
